Immune infiltration of tumor microenvironment following immunotherapy for glioblastoma multiforme

References

• Stupp R, Mason WP, Van Den Bent Martin J, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352(10):987–96. doi:10.1056/NEJMoa043330. PMID:15758009
   PubMed Web of Science ®Google Scholar
• MacCarty WC. Factors which influence longevity in cancer. Ann Surg. 1922;76(1):9–12; PMID:17864672
   PubMedGoogle Scholar
• Wade H. Of its relationship to cancer. J Pathol Bacteriol. 1908;12:384. doi:10.1002/path.1700120221
   Google Scholar
• Hamlin IM. Possible host resistance in carcinoma of the breast: A histological study. Br J Cancer. 1968;22(3):383–401. doi:10.1038/bjc.1968.47. PMID:5681002
   PubMed Web of Science ®Google Scholar
• Husby G, Hoagland PM, Strickland RG, Williams RC, Jr. Tissue T and B cell infiltration of primary and metastatic cancer. J Clin Invest. 1976;57(6):1471–1482. doi:10.1172/JCI108417. PMID:180052
   PubMed Web of Science ®Google Scholar
• Bertrand I, Mannen H. Etude des reactions vasculaires dans les astrocytomes. Rev Neurol. 1960;102:3–19
   Google Scholar
• Palma L, Di Lorenzo N, Guidetti B. Lymphocytic infiltrates in primary glioblastomas and recidivous gliomas: Incidence, fate, and relevance to prognosis in 228 operated cases. J Neurosurg. 1978;49(6):854–61. doi:10.3171/jns.1978.49.6.0854. PMID:731302
   PubMed Web of Science ®Google Scholar
• Goldmann J, Kwidzinski E, Brandt C, Mahlo J, Richter D, Bechmann I. T cells traffic from brain to cervical lymph nodes via the cribroid plate and the nasal mucosa. J Leukoc Biol. 2006;80(4):797–801. doi:10.1189/jlb.0306176. PMID:16885505
   PubMed Web of Science ®Google Scholar
• Polyzoidis S, Tuazon J, Brazil L, Beaney R, Al-Sarraj ST, Doey L, Logan J, Hurwitz V, Jarosz J, Bhangoo R, et al. Active dendritic cell immunotherapy for glioblastoma: Current status and challenges. Br J Neurosurg. 2015;29(2):197–205. doi:10.3109/02688697.2014.994473. PMID:25541743
   PubMed Web of Science ®Google Scholar
• Ochs K, Sahm F, Opitz CA, Lanz TV, Oezen I, Couraud PO, von Deimling A, Wick W, Platten M. Immature mesenchymal stem cell-like pericytes as mediators of immunosuppression in human malignant glioma. J Neuroimmunol. 2013;265(1):106–16. doi:10.1016/j.jneuroim.2013.09.011. PMID:24090655
   PubMed Web of Science ®Google Scholar
• Sims JS, Ung TH, Neira JA, Canoll P, Bruce JN. Biomarkers for glioma immunotherapy: The next generation. J Neurooncol. 2015;123(3):359–72
   PubMed Web of Science ®Google Scholar
• Smyth MJ, Godfrey DI, Trapani JA. A fresh look at tumor immunosurveillance and immunotherapy. Nat Immunol. 2001;2(4):293–99. doi:10.1038/86297. PMID:11276199
   PubMed Web of Science ®Google Scholar
• Sampson JH, Archer GE, Ashley DM, Fuchs HE, Hale LP, Dranoff G, Bigner DD. Subcutaneous vaccination with irradiated, cytokine-producing tumor cells stimulates CD8+ cell-mediated immunity against tumors located in the “immunologically privileged” central nervous system. Proc Natl Acad Sci U S A. 1996;93(19):10399–404. doi:10.1073/pnas.93.19.10399. PMID:8816812
   PubMed Web of Science ®Google Scholar
• Liau LM, Black KL, Prins RM, Sykes SN, DiPatre PL, Cloughesy TF, Becker DP, Bronstein JM. Treatment of intracranial gliomas with bone marrow-derived dendritic cells pulsed with tumor antigens. J Neurosurg. 1999;90(6):1115–24. doi:10.3171/jns.1999.90.6.1115. PMID:10350260
   PubMed Web of Science ®Google Scholar
• Broder H, Anderson A, Kremen TJ, Odesa SK, Liau LM. MART-1 adenovirus-transduced dendritic cell immunization in a murine model of metastatic central nervous system tumor. J Neurooncol. 2003;64(1-2):21–30. doi:10.1007/BF02700017. PMID:12952283
   PubMed Web of Science ®Google Scholar
• Siesjö P, Visse E, Sjögren HO. Cure of established, intracerebral rat gliomas induced by therapeutic immunizations with tumor cells and purified APC or adjuvant IFN-U03B3 treatment. Journal of Immunotherapy. 1996;19(5):334–45. doi:10.1097/00002371-199609000-00003. PMID:8941873
   PubMed Web of Science ®Google Scholar
• Hsu FJ, Benike C, Fagnoni F, Liles TM, Czerwinski D, Taidi B, Engleman EG, Levy R. Vaccination of patients with b–cell lymphoma using autologous antigen–pulsed dendritic cells. Nat Med. 1996;2(1):52–8. doi:10.1038/nm0196-52. PMID:8564842
   PubMed Web of Science ®Google Scholar
• Nestle FO, Alijagic S, Gilliet M, Sun Y, Grabbe S, Dummer R, Burg G, Schadendorf D. Vaccination of melanoma patients with peptide-or tumorlysate-pulsed dendritic cells. Nat Med. 1998;4(3):328–32. doi:10.1038/nm0398-328. PMID:9500607
   PubMed Web of Science ®Google Scholar
• Tjoa B, Simmons S, Bowes V, Ragde H, Rogers M, Elgamal A, Kenny GM, Cobb OE, Ireton RC, Troychak MJ, et al. Evaluation of phase I/II clinical trials in prostate cancer with dendritic cells and PSMA peptides. Prostate. 1998;36(1):39–44. doi:10.1002/(SICI)1097-0045(19980615)36:1%3c39::AID-PROS6%3e3.0.CO;2-6. PMID:9650914
   PubMed Web of Science ®Google Scholar
• Kugler A, Stuhler G, Walden P, Zöller G, Zobywalski A, Brossart P, Trefzer U, Ullrich S, Müller CA, Becker V, Gross AJ, Hemmerlein B, Kanz L, Muller GA, Ringert R-H. Regression of human metastatic renal cell carcinoma after vaccination with tumor cell–dendritic cell hybrids. Nat Med. 2000;6(3):332–36. doi:10.1038/73193. PMID:10700237
   PubMed Web of Science ®Google Scholar
• Sabado RL, Bhardwaj N. Dendritic cell immunotherapy. Ann N Y Acad Sci. 2013;1284(1):31–45. doi:10.1111/nyas.12125. PMID:23651191
   PubMed Web of Science ®Google Scholar
• Liau LM, Prins RM, Kiertscher SM, Odesa SK, Kremen TJ, Giovannone AJ, Lin JW, Chute DJ, Mischel PS, Cloughesy TF, Roth MD. Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment. Clin Cancer Res. 2005;11(15):5515–25. doi:10.1158/1078-0432.CCR-05-0464. PMID:16061868
   PubMed Web of Science ®Google Scholar
• Yamanaka R, Homma J, Yajima N, Tsuchiya N, Sano M, Kobayashi T, Yoshida S, Abe T, Narita M, Takahashi M, Tanaka R. Clinical evaluation of dendritic cell vaccination for patients with recurrent glioma: Results of a clinical phase I/II trial. Clin Cancer Res. 2005;11(11):4160–67. doi:10.1158/1078-0432.CCR-05-0120. PMID:15930352
   PubMed Web of Science ®Google Scholar
• Chang C, Huang Y, Yang D, Kikuta K, Wei KJ, Kubota T, Yang WK. A phase I/II clinical trial investigating the adverse and therapeutic effects of a postoperative autologous dendritic cell tumor vaccine in patients with malignant glioma. J Clin Neurosci. 2011;18(8):1048–54. doi:10.1016/j.jocn.2010.11.034. PMID:21715171
   PubMed Web of Science ®Google Scholar
• Yu JS, Liu G, Ying H, Yong WH, Black KL, Wheeler CJ. Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma. Cancer Res. 2004;64(14):4973–79. doi:10.1158/0008-5472.CAN-03-3505. PMID:15256471
   PubMed Web of Science ®Google Scholar
• Prins RM, Soto H, Konkankit V, Odesa SK, Eskin A, Yong WH, Nelson SF, Liau LM. Gene expression profile correlates with T-cell infiltration and relative survival in glioblastoma patients vaccinated with dendritic cell immunotherapy. Clin Cancer Res. 2011;17(6):1603–15. doi:10.1158/1078-0432.CCR-10-2563. PMID:21135147
   PubMed Web of Science ®Google Scholar
• Walker DG, Laherty R, Tomlinson FH, Chuah T, Schmidt C. Results of a phase I dendritic cell vaccine trial for malignant astrocytoma: Potential interaction with adjuvant chemotherapy. J Clin Neurosci. 2008;15(2):114–21. doi:10.1016/j.jocn.2007.08.007. PMID:18083572
   PubMed Web of Science ®Google Scholar
• Steiner HH, Bonsanto MM, Beckhove P, Brysch M, Geletneky K, Ahmadi R, Schuele-Freyer R, Kremer P, Ranaie G, Matejic D, et al. Antitumor vaccination of patients with glioblastoma multiforme: A pilot study to assess feasibility, safety, and clinical benefit. J Clin Oncol. 2004;22(21):4272–81. doi:10.1200/JCO.2004.09.038. PMID:15452186
   PubMed Web of Science ®Google Scholar
• Liau LM, Jensen ER, Kremen TJ, Odesa SK, Sykes SN, Soung MC, Miller JF, Bronstein JM. Tumor immunity within the central nervous system stimulated by recombinant listeria monocytogenes vaccination. Cancer Res. 2002;62(8):2287–93; PMID:11956085
   PubMed Web of Science ®Google Scholar
• Yamanaka R, Homma J, Yajima N, Tsutiya N, Takahashi M, Tanaka R. Vaccination of recurrent glioma patients with tumour lysate-pulsed dendritic cells elicits immune responses: Results of a clinical phase I/II trial. Cancer Res. 2004;64(7 Supplement):283–283
   Google Scholar
• Clark WH, Jr, Elder DE, Guerry D, 4th, Braitman LE, Trock BJ, Schultz D, Synnestvedt M, Halpern AC. Model predicting survival in stage I melanoma based on tumor progression. J Natl Cancer Inst. 1989;81(24):1893–904. doi:10.1093/jnci/81.24.1893. PMID:2593166
   PubMed Web of Science ®Google Scholar
• Clemente CG, Mihm MC, Bufalino R, Zurrida S, Collini P, Cascinelli N. Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma. Cancer. 1996;77(7):1303–10. doi:10.1002/(SICI)1097-0142(19960401)77:7%3c1303::AID-CNCR12%3e3.0.CO;2-5. PMID:8608507
   PubMed Web of Science ®Google Scholar
• Mihm MC, Jr, Clemente CG, Cascinelli N. Tumor infiltrating lymphocytes in lymph node melanoma metastases: A histopathologic prognostic indicator and an expression of local immune response. Lab Invest. 1996;74(1):43–7; PMID:8569196
   PubMed Web of Science ®Google Scholar
• Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P, Evdemon-Hogan M, Conejo-Garcia JR, Zhang L, Burow M, et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med. 2004;10(9):942–949. doi:10.1038/nm1093. PMID:15322536
   PubMed Web of Science ®Google Scholar
• Zhang L, Conejo-Garcia JR, Katsaros D, Gimotty PA, Massobrio M, Regnani G, Makrigiannakis A, Gray H, Schlienger K, Liebman MN, Rubin SC, Coukos G. Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med. 2003;348(3):203–13. doi:10.1056/NEJMoa020177. PMID:12529460
   PubMed Web of Science ®Google Scholar
• Naito Y, Saito K, Shiiba K, Ohuchi A, Saigenji K, Nagura H, Ohtani H. CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. Cancer Res. 1998;58(16):3491–94; PMID:9721846
   PubMed Web of Science ®Google Scholar
• Walker DG, Chuah T, Rist MJ, Pender MP. T-cell apoptosis in human glioblastoma multiforme: Implications for immunotherapy. J Neuroimmunol. 2006;175(1):59–68. doi:10.1016/j.jneuroim.2006.03.006. PMID:16631933
   PubMed Web of Science ®Google Scholar
• Yang I, Tihan T, Han SJ, Wrensch MR, Wiencke J, Sughrue ME, Parsa AT. CD8 T-cell infiltrate in newly diagnosed glioblastoma is associated with long-term survival. J Clin Neurosci. 2010;17(11):1381–5. doi:10.1016/j.jocn.2010.03.031. PMID:20727764
   PubMed Web of Science ®Google Scholar
• Boker DK, Kalff R, Gullotta F, Weekes-Seifert S, Mohrer U. Mononuclear infiltrates in human intracranial tumors as a prognostic factor. influence of preoperative steroid treatment. I. glioblastoma. Clin Neuropathol. 1984;3(4):143–7; PMID:6478676
   PubMed Web of Science ®Google Scholar
• Brooks W, Markesbery W, Gupta G, Roszman T. Relationship of lymphocyte invasion and survival of brain tumor patients. Ann Neurol. 1978;4(3):219–24. doi:10.1002/ana.410040305. PMID:718133
   PubMed Web of Science ®Google Scholar
• Safdari H, Hochberg FH, Richardson EP. Prognostic value of round cell (lymphocyte) infiltration in malignant gliomas. Surg Neurol. 1985;23(3):221–26. doi:10.1016/0090-3019(85)90086-2. PMID:2983448
   PubMedGoogle Scholar
• Rossi M, Jones N, Candy E, Nicoll JA, Compton JS, Hughes JT, Esiri MM, Moss TH, Cruz-Sanchez FF, Coakham HB. The mononuclear cell infiltrate compared with survival in high-grade astrocytomas. Acta Neuropathol. 1989;78(2):189–93. doi:10.1007/BF00688208. PMID:2750489
   PubMed Web of Science ®Google Scholar
• Schiffer D, Cavicchioli D, Giordana MT, Palmucci L, Piazza A. Analysis of some factors effecting survival in malignant gliomas. Tumori. 1979;65(1):119–25; PMID:220763
   PubMed Web of Science ®Google Scholar
• Authier A, Farrand KJ, Broadley KW, Ancelet LR, Hunn MK, Stone S, McConnell MJ, Hermans IF. Enhanced immunosuppression by therapy‐exposed glioblastoma multiforme tumor cells. Int J Cancer. 2015;136(11):2566–78. doi:10.1002/ijc.29309. PMID:25363661
   PubMed Web of Science ®Google Scholar
• Yu JS, Wheeler CJ, Zeltzer PM, Ying H, Finger DN, Lee PK, Yong WH, Incardona F, Thompson RC, Riedinger MS, et al. Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration. Cancer Res. 2001;61(3):842–7; PMID:11221866
   PubMed Web of Science ®Google Scholar
• Yang Y, Lu J, Liu H, Jin G, Bai R, Li X, Wang D, Zhao J, Huang Y, Liu K, et al. Dendritic cells loading autologous tumor lysate promote tumor angiogenesis. Tumor Biol. 2016;37(12):15687–95
   Google Scholar
• Hsu M, Sedighim S, Wang T, Antonios JP, Everson RG, Tucker AM, Du L, Emerson R, Yusko E, Sanders C, et al. TCR sequencing can identify and track glioma-infiltrating T cells after DC vaccination. Cancer Immunol Res. 2016;4(5):412–8.
   PubMed Web of Science ®Google Scholar
• Everson RG, Jin RM, Wang X, Safaee M, Scharnweber R, Lisiero DN, Soto H, Liau LM, Prins RM. Cytokine responsiveness of CD8 T cells is a reproducible biomarker for the clinical efficacy of dendritic cell vaccination in glioblastoma patients. J Immunother Cancer. 2014;2(1):1. doi:10.1186/2051-1426-2-10. PMID:24829758
   PubMedGoogle Scholar
• Kamran N, Calinescu A, Candolfi M, Chandran M, Mineharu Y, Asad AS, Koschmann C, Nunez FJ, Lowenstein PR, Castro MG. Recent advances and future of immunotherapy for glioblastoma. Expert Opin Biol Ther. 2016;16(10):1245–64. doi:10.1080/14712598.2016.1212012. PMID:27411023
   PubMed Web of Science ®Google Scholar
• Libard S, Popova SN, Amini R, Kärjä V, Pietiläinen T, Hämäläinen KM, Sundström C, Hesselager G, Bergqvist M, Ekman S, et al. Human cytomegalovirus tegument protein pp65 is detected in all intra-and extra-axial brain tumours independent of the tumour type or grade. PloS one. 2014;9(9):e108861. doi:10.1371/journal.pone.0108861. PMID:25268364
   PubMed Web of Science ®Google Scholar
• Shamran HA, Kadhim HS, Hussain AR, Kareem A, Taub DD, Price RL, Nagarkatti M, Nagarkatti PS, Singh UP. Detection of human cytomegalovirus in different histopathological types of glioma in iraqi patients. BioMed Res Int. 2015;2015:642652
   PubMed Web of Science ®Google Scholar